New Onmark Benchmarking Survey Shows Treating Patients in the Office With Specialty Drugs is Critical to Rheumatologists’ Revenue Streams  
1/6/2009 10:02:54 AM

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Onmark, a leading national group purchasing organization (GPO) for community-based medical practices and a McKesson Specialty Care Solutions company, found that rheumatologists rely on specialty drugs purchased and administered to patients for practice revenue streams. At the same time, these specialty drugs represent the largest percentage of costs incurred by practices.